Walleye Capital’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,288
| Closed | -$37K | – | 2674 |
|
|
2022
Q1 | $37K | Sell |
3,288
-2,149
| -40% | -$24.2K | ﹤0.01% | 1802 |
|
|
2021
Q4 | $79K | Buy |
5,437
+4,176
| +331% | +$60.7K | ﹤0.01% | 1672 |
|
|
2021
Q3 | $38 | Sell |
1,261
-3,324
| -72% | -$100 | ﹤0.01% | 1392 |
|
|
2021
Q2 | $213 | Buy |
+4,585
| New | +$213 | 0.01% | 1028 |
|
|
2020
Q4 | – | Sell |
-4,610
| Closed | -$159K | – | 1104 |
|
|
2020
Q3 | $159K | Buy |
+4,610
| New | +$159K | 0.02% | 642 |
|
|
2020
Q1 | – | Sell |
-1,704
| Closed | -$123K | – | 951 |
|
|
2019
Q4 | $123K | Buy |
+1,704
| New | +$123K | 0.01% | 449 |
|